Lv62
2730 积分 2022-11-29 加入
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry
10天前
已完结
Pathogensis and treatments for high altitude pulmonary hypertension: an updated review
10天前
已完结
Prime Time for Proteomics in PAH Risk Assessment?
12天前
已完结
Molecular genetic framework underlying pulmonary arterial hypertension
12天前
已完结
Idiopathic Pulmonary Arterial Hypertension: Network-Based Integration of Multi-Omics Data Reveals New Molecular Signatures and Candidate Drugs
13天前
已完结
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension
13天前
已完结
The application of ‘omics’ to pulmonary arterial hypertension
13天前
已完结
Health benefits of spices in individuals with chemotherapeutic drug-induced cardiotoxicity
17天前
已完结
Current Therapeutic Approaches to Pulmonary Arterial Hypertension
20天前
已完结
皖公网安备34019202002308
